Elsevier

Journal of Autoimmunity

Volume 7, Issue 5, October 1994, Pages 623-631
Journal of Autoimmunity

Regular Article
The bc1-2 Proto-Oncogene is Overexpressed in Systemic Lupus Erythematosus

https://doi.org/10.1006/jaut.1994.1046Get rights and content

Abstract

Systemic Lupus Erythematosus (SLE) is a disease in which lymphoid hyper-reactivity occurs. Whether this is primary or secondary is not always clear. SLE occurs on a well defined genetic background including genes associated with the major histocompatibility complex (MHC) although family studies demonstrate that other genes must be involved as well. Other potential genes include those involved in intrinsic lymphoid hyper-reactivity, for example by preventing programmed cell death. Such examples exist in murine models of SLE, and in this study we provide evidence that one such controlling protein, bc1-2, is expressed in an increased proportion of both B and T cells in SLE patients. The increased expression was not readily related to disease activity measured by the SIS, nor by routine serological markers. This raises the possibility that the increased expression of bc1-2 seen in lymphoid cells from SLE patients may be of intrinsic genetic origin rather than being secondary to the auto-reactive process. Such increased expression could be expected to interfere with programmed cell death, to produce lymphoid hyper-reactivity and to contribute to the induction and maintenance of this prototype systemic autoimmune disease.

References (0)

Cited by (43)

  • Cell- and nuclear-penetrating anti-dsDNA autoantibodies have multiple arginines in CDR3 of VH and increase cellular level of pERK and Bcl-2 in mesangial cells

    2015, Molecular Immunology
    Citation Excerpt :

    It is possible that cell death or proliferation inhibition induced by anti-dsDNA Ab treatment might load stress on cells to trigger cell survival signals. However, there have been several reports showing relates of Bcl-2 increment and the induction of cell death in SLE, although contradictory opinion exists; increased expression of Bcl-2 as well as increased tendency to undergo apoptosis were found in SLE bone marrow cells and T lymphocytes (Gatenby and Irvine, 1994; Ohsako et al., 1994); a role of cytokine-induced enhancement of Bcl-2 expression in the pathogenesis of SLE was suggested (Graninger et al., 2000). The deregulated cell survival affected by the abnormally controlled cytokine network could be another possible explanation for our observations.

  • Identification of autoantibodies associated with systemic lupus erythematosus

    2002, Biochemical and Biophysical Research Communications
  • Apoptosis in arthritis - Pathogenesis and therapeutic intervention

    2001, Advances in Cell Aging and Gerontology
  • Genetics of systemic lupus erythematosus: Clinical implications

    2000, Rheumatic Disease Clinics of North America
    Citation Excerpt :

    Overexpression of Bcl-2 in mice leads to enhanced survival of B cells and an autoimmune phenotype.150 Patients with SLE have been shown to overexpress Bcl-2, and this has led to the hypothesis that this overexpression contributes to the development of autoreactive B cells.5,60 A minisatellite analysis of Mexican-American patients with SLE revealed an association of Bcl-2 polymorphisms with SLE.109

View all citing articles on Scopus
View full text